VisionPoint Advisory Group’s CVS Health CVS Stock Holding History

VisionPoint Advisory Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-2,585	Closed	-$267K	–	474
2026 Q2	$267K	Buy	+2,585	New	+$231K	0.04%	390
2024 Q3	–	Sell	-239	Closed	-$14.1K	–	357
2024 Q2	$14.1K	Sell	239 -72	-23%	-$4.5K	0.01%	454
2024 Q1	$24.8K	Sell	311 -9	-3%	-$687	0.01%	361
2023 Q4	$25.3K	Sell	320 -1,284	-80%	-$91.4K	0.01%	332
2023 Q3	$112K	Buy	1,604 +1,338	+503%	+$94.8K	0.05%	180
2023 Q2	$18.4K	Buy	+266	New	+$18.9K	0.01%	297
2020 Q1	–	Sell	-4,180	Closed	-$311K	–	124
2019 Q4	$311K	Buy	4,180 +90	+2%	+$6.32K	0.13%	86
2019 Q3	$255K	Buy	4,090 +78	+2%	+$4.62K	0.07%	115
2019 Q2	$219K	Buy	+4,012	New	+$216K	0.06%	123

Other funds holding CVS

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

VisionPoint Advisory Group's CVS Position: Q3 2026 in Review

VisionPoint Advisory Group sold out of CVS Health (CVS) in Q3 2026, closing a stake of 2,585 shares — an estimated $267K sold.

VisionPoint Advisory Group first reported a position in CVS in Q2 2019 and held it in 9 quarters. The position peaked at $311K in Q4 2019. 552 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

VisionPoint Advisory Group reported no remaining CVS Health position as of Q3 2026 after selling out during the quarter.
VisionPoint Advisory Group sold 2,585 CVS Health shares in Q3 2026, an estimated $267K.
VisionPoint Advisory Group first reported a position in CVS Health in Q2 2019 and held it in 9 quarters.
VisionPoint Advisory Group's CVS Health position peaked at $311K in Q4 2019.
552 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on VisionPoint Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.